AUTHOR=Kang Jiman , Liggett Jedson R. , Patil Digvijay , Ranjit Suman , Loh Katrina , Duttargi Anju , Cui Yuki , Oza Kesha , Frank Brett S. , Kwon DongHyang , Kallakury Bhaskar , Robson Simon C. , Fishbein Thomas M. , Cui Wanxing , Khan Khalid , Kroemer Alexander TITLE=Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers JOURNAL=Frontiers in Immunology VOLUME=13 YEAR=2022 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.899525 DOI=10.3389/fimmu.2022.899525 ISSN=1664-3224 ABSTRACT=
Innate lymphoid cells (ILCs), the most recently described family of lymphoid cells, play fundamental roles in tissue homeostasis through the production of key cytokine. Group 1 ILCs, comprised of conventional natural killer cells (cNKs) and type 1 ILCs (ILC1s), have been implicated in regulating immune-mediated inflammatory diseases. However, the role of ILC1s in nonalcoholic fatty liver disease (NAFLD) and ischemia-reperfusion injury (IRI) is unclear. Here, we investigated the role of ILC1 and cNK cells in a high-fat diet (HFD) murine model of partial warm IRI. We demonstrated that hepatic steatosis results in more severe IRI compared to non-steatotic livers. We further elicited that HFD-IRI mice show a significant increase in the ILC1 population, whereas the cNK population was unchanged. Since ILC1 and cNK are major sources of IFN-γ and TNF-α, we measured the level of